中文别名 |
恩他卡朋;(E)-2-氰基-3-(3,4二羟基-5-硝基苯)-N,N二乙基丙烯酰胺;(E)-2-氰基-3-(3,4二羟基-5-硝基;安托卡朋F·S;恩他卡朋 EP标准品;恩他卡朋 USP标准品;恩他卡朋-D10;尼卡地平中间体;乙氧嘧磺隆;(2E)-2-氰基-3-(3,4-二羟基-5-硝基苯基)-N,N-二乙基-2-丙烯酰胺;(E)-2-氰基-3-(3,4-二羟基-5-硝基苯基)-N,N-二乙基-2-丙烯酰胺;安托卡朋;恩他卡;COMT抑制剂;安托卡朋 F·S |
英文别名 |
Entacapone;2-cyano-3-(5-dihydroxyamino-3,4-dioxo-1-cyclohexa-1,5-dienyl)-n,n-diethyl-prop-2-enamide;2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide;Comtan;Comtes;Comtess;OR-611;ENTACAPONE F·S;Entacapone (150 mg);Entacapone (isomer E);(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide;(E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-pmpenamide;ENTACAPONE [EMA EPAR];Entacapone [USAN:USP:INN:BAN];OR611;SR-05000001452;CHEBI:4798;NCGC00164555-03;AB01275450_02;(E)-Entacapone;s3147;Entacapona (INN-Spanish);DTXSID5046439;Comtan (TN);CAS-130929-57-6;AB01275450-01;SR-05000001452-3;BDBM50108879;D00781;130929-57-6;(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide;SCHEMBL13596593;HMS3713B20;Entacaponum [INN-Latin];ENTACAPONE (MART.);ENTACAPONE [USP-RS];AB01275450_03;2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-;ENTACAPONE [USAN];JRURYQJSLYLRLN-BJMVGYQFSA-N;ENTACAPONE COMPONENT OF STALEVO;(E)-2-cyano-N,N-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide;ENTACAPONE [JAN];A922031;A806167;Entacaponum;HMS2089O16;CCG-213064;EX-A1130;Tox21_112184_1;Entacapone orion;NCGC00164555-02;Entacapona;BCP9000645;J-008069;(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide;ENTACAPONE (USP-RS);PD9;ENTACAPONE (EP MONOGRAPH);NCGC00164555-01;AKOS015965009;GTPL6647;C07943;ENTACAPONE (USP MONOGRAPH);SCHEMBL34505;Entacapone teva;HY-14280;NS00006886;HMS3885K09;CORBILTA COMPONENT ENTACAPONE;ENTACAPONE [VANDF];Q416444;J-005902;MFCD00866580;ENTACAPONE [ORANGE BOOK];STALEVO COMPONENT ENTACAPONE;SCHEMBL34504;(2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide;AKOS015907685;N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide;OR 611;CS-1266;ENTACAPONE [USP MONOGRAPH];(E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide;ENTACAPONE [EP MONOGRAPH];CHEMBL953;HSDB 8251;Entacaponum (INN-Latin);(~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide;N04BX02;(E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide;LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT ENTACAPONE;BIDD:GT0026;(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide;4975G9NM6T;DTXCID3026439;2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-n,n-diethyl-2-propenamide;SR-05000001452-2;ENTACAPONE [MART.];(E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide;2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-;ENTACAPONE COMPONENT OF CORBILTA;ENTACAPONE [INN];116314-67-1;COM-998;Entacapona [INN-Spanish];UNII-4975G9NM6T;DB00494;E0961;Entacaponum (Latin);ENTACAPONE COMPONENT OF LEVODOPA/CARBIDOPA/ENTACAPONE ORION;SR-05000001452-1;NCGC00164555-10;Entacom;SW199035-2;(E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide;AC-393;Tox21_112184;Entacapone (JP17/USP/INN);BRD-K83636919-001-0... |